• 4 ASX tech shares to buy that aren’t BNPL shares

    ASX tech shares

    Buy now, pay later (BNPL) shares have stolen the limelight from the ASX tech sector. BNPL shares have become increasingly challenging to buy as valuations continue to be stretched. With reporting season around the corner, here are 4 ASX tech shares with reasonable valuations and strong growth portfolios. 

    1. Data#3 Ltd (ASX: DTL) 

    Data3 delivers an integrated array of solutions spanning cloud, modern workplace, security, data and analytics, and connectivity. These technology solutions are delivered by combining its services across consulting, project services and support services.

    On 16 July, the company advised that, subject to finalisation of its group year-end audit, its consolidated net profit before tax for FY20 is estimated to be approximately $34 million. This represents an increase of 28% compared to its previous record FY19 result. 

    2. Bigtincan Holdings Ltd (ASX: BTH) 

    Bigtincan is a global leader in sales enablement software, which allows organisations to increase sales win rates, reduce expenditure and improve customer satisfaction. In its equity capital raising presentation back in May, the company cited that its customer cash receipts increased 178% to $14.9 million from the March 2019 quarter of $5.4 million. This growth was driven by significant new wins with a number of Fortune 500 companies.

    I believe Bigtincan represents a more volatile opportunity that could deliver some explosive growth in the medium-long term. For investors looking for a slightly speculative opportunity, this could be the ASX tech share to add to your watchlist. 

    3. Rhipe Ltd (ASX: RHP) 

    Rhipe provides licensing, business development and knowledge services that support its customers’ adoption of cloud technologies. Its vendors – such as Microsoft, VMWare and Citrix – all rely on Rhipe’s platform to build, grow and support the consumption of their cloud license programs.

    On 17 April, the company provided a trading update highlighting its unaudited trading results for the nine months to 31 March 2020. During this period, the company delivered a 32% increase in sales and 19% increase in revenue. Following this announcement, Rhipe initiated a $34 million capital raising to allow it to pursue acquisitions that are complementary to its existing cloud software subscription business. I believe Rhipe has demonstrated fair growth and is now in a strong cash position to explore opportunities to accelerate its growth moving forward. 

    4. Dicker Data Ltd (ASX: DDR) 

    Dicker Data is a value added distributor of hardware, software, cloud and emerging technologies in Australia. In the company’s market update announced on 23 July, it outlined the recent surge in remote work has seen a strong demand for remote and virtual working solutions across its hardware and software portfolios.

    The company provided unaudited half year results that saw its total revenue increase 18.1% and net profit after tax up 23.5%. Dicker is one of the few ASX tech shares that do not trade at an outrageous valuation. At today’s prices, its price-to-earnings ratio is just 21. I believe the company represents good value and further sales tailwinds can be expected.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Lina Lim has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends BIGTINCAN FPO. The Motley Fool Australia owns shares of and has recommended Dicker Data Limited. The Motley Fool Australia has recommended BIGTINCAN FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 4 ASX tech shares to buy that aren’t BNPL shares appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3f02adz

  • The Growth Story Remains for Alibaba Stock Despite Troubles in India

    The Growth Story Remains for Alibaba Stock Despite Troubles in IndiaAlibaba (NYSE:BABA) stock had a rare bad run last week, falling almost 6%.Source: testing / Shutterstock.com Considering its attractive business model and historical growth multiples, many analysts would find this development surprising. However, escalating tensions in Southeast Asia and a resurgent novel coronavirus are pushing the stock down.Still, these developments have little to do with the operational metrics of the business. Hence, I believe there are plenty of reasons to remain bullish on Alibaba stock stock. Chinese demand is rebounding, and the U.S. economy is also showing signs of life. Meanwhile, the business-to-business platform operated by Alibaba continues to give it a significant leg-up on its competition, especially with respect to its more famous American counterpart, Amazon (NASDAQ:AMZN).InvestorPlace – Stock Market News, Stock Advice & Trading TipsDespite the occasional hiccup, Alibaba stock has a lot going for it. You won't go wrong investing in this one. What Sets Alibaba Stock Apart?The reason why Alibaba is different from a lot of its peers is the unique business model. Although it did not pioneer the business-to-business e-commerce system, it is now its foremost expert, giving it a massive edge over the likes of Amazon, which operates a business-to-customer model. * 10 Cybersecurity Stocks We Need Now More Than Ever The critical difference between the two systems is that Alibaba does not need logistics facilities and warehouses to store goods that need to be shipped. Not having to do so makes for higher operating margins. Even from a liquidity standpoint, Alibaba is cash-rich, and its debt-equity ratio stands at 0.20 times, which is prudent, considering the industry average is 0.67 times. China-India Tensions Are Pressuring Alibaba StockThe Indian government's decision to ban 59 Chinese apps has jolted several Chinese tech companies, including Tencent Holdings (OTCMKTS:TCEHY), Baidu (NASDAQ:BIDU) and Alibaba.This is not great news for Alibaba. The tech giant has long sought to diversify its revenue sources away from China to other geographies. But those ambitions have hit a snag due to tensions between the two nuclear-armed states.Since we are still in the early days of this conflict, we don't know where this is going. At the moment, the administration of Prime Minister Narendra Modi is targeting apps developed in China. However, the government may want to punish every company that has even the remotest link to Beijing.For example, Alibaba has a significant stake in several platforms in India. Through two subsidiaries, the company holds a 40% share in payment app Paytm. Meanwhile, Alibaba affiliate, Ant Group, formerly known as Alipay, is the largest stakeholder in Zomato, India's most prominent food delivery provider.A recent news report revealed that due to rising tensions, the company could find it challenging to tap into the $100 million equity capital it attracted in its last funding round from Ant. U.S.-China Trade IssuesThe recent troubles in India come at a particularly bad time for Alibaba. Just a month ago, the U.S. Senate passed a bill that imposed greater regulation on Chinese companies. According to the law, any company found in violation of U.S. Securities and Exchange Commission rules could face delisting.There are several reasons why the bill was tabled in the first place. Although trade tensions between the U.S. and China are on the decline, there is still a lot of bad blood. There is also a feeling in Washington that companies that are either indirectly or directly controlled by the Chinese government must face greater scrutiny.Finally, fraud cases like Luckin Coffee (OTCMKTS:LKNCY) reinforce the notion that the regulatory environment in China is not as robust as the U.S., so there is a need for greater regulation when dealing with Chinese companies. Ant Group IPOOne of the driving forces of Alibaba stock stock recently has been the impending IPO of Ant Group, formerly known as Ant Financial. The fintech firm has revealed that the IPO will take place simultaneously on the Hong Kong Stock Exchange and Shanghai Stock Exchange's Star Market.Reuters said that bankers are valuing the IPO at over $200 billion. It's a no-brainer that every Chinese investor would love to get their hands on this company, considering that it's a crucial linchpin in digitizing China's service industry. My Final WordAlthough I have highlighted a significant number of risks Alibaba is facing, I remain bullish on the stock. It has an attractive business model and wide moat, relative to peer Amazon, Alibaba stock trades at a 33.78x trailing price-earnings ratio. That may seem steep, but Amazon trades at 152.74x, just to put things in perspective.The company's ambitions to spread its wings beyond China may not have borne fruit. But there is plenty to cheer for if you are an investor that values fundamentals. The business model remains enticing, holdings are diversified, and its business divisions are flourishing. Covid-19 has also done little to dent the company's business prospects. In fact, it has led to increased traffic on Alibaba's various platforms.Bottom line: You can't go wrong parking your capital in the Asian tech juggernaut.Faizan Farooque is a contributing author for InvestorPlace.com and numerous other financial sites. He has several years of experience in analyzing the stock market and was a former data journalist at S&P Global Market Intelligence. His passion is to help the average investor make more informed decisions regarding their portfolio. He does not directly own the securities mentioned above. More From InvestorPlace * Why Everyone Is Investing in 5G All WRONG * America's 1 Stock Picker Reveals His Next 1,000% Winner * Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company * Radical New Battery Could Dismantle Oil Markets The post The Growth Story Remains for Alibaba Stock Despite Troubles in India appeared first on InvestorPlace.

    from Yahoo Finance https://ift.tt/3eYi2gI

  • 3 stellar ASX tech shares I would buy in August

    asx tech shares

    If you’re looking to add some tech shares to your portfolio in August, then I think the three listed below could be ones to consider buying.

    Here’s why I think these ASX tech shares could be destined for big things:

    Nearmap Ltd (ASX: NEA)

    Nearmap is a leading aerial imagery technology and location data company. Its software allows its users to move location analysis out of the field and into the office. It gives businesses instant access to high resolution aerial imagery, city-scale 3D datasets, and integrated geospatial tools. I think Nearmap could have a bright future ahead of it thanks to its high quality solutions and its lucrative opportunity in a highly fragmented market. All in all, I believe the Nearmap share price could be a market beater over the 2020s.

    Xero Limited (ASX: XRO)

    Another ASX tech share to consider buying is Xero. It is one of the world’s leading cloud-based business and accounting software providers. Thanks to the ongoing shift to cloud accounting, Xero has been growing at a rapid rate in recent years. This continued in FY 2020 with Xero reporting a 29% lift in annualised monthly recurring revenue (AMRR) to NZ$820.6 million. This was driven by strong customer growth and its sky high retention rate. I believe the latter demonstrates the quality and stickiness of its accounting platform. Looking ahead, I believe the company has a long runway for growth. Particularly in the North America market where it currently has just 241,000 subscribers. This compares to 914,000 subscribers in a materially smaller ANZ market.

    Zip Co Ltd (ASX: Z1P)

    A final tech share to consider buying is Zip Co. It is one of the ANZ region’s leading buy now pay later providers. While its shares have been on fire this year, I believe they could still be a great long term option for investors. Especially given its recent expansion into the massive United States market via the acquisition of QuadPay. If the company can make a success of this expansion, it could be destined for further explosive growth over the coming years.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Nearmap Ltd., Xero, and ZIPCOLTD FPO. The Motley Fool Australia has recommended Nearmap Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 stellar ASX tech shares I would buy in August appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2WSfJ8A

  • Why I’d start planning for stock market crash part 2 today

    man with head in hands after looking at stock market crash on computer, asx 200 share market crash

    A second stock market crash could realistically occur over the coming months. Numerous risks face the world economy that could derail its growth prospects and cause investor sentiment to weaken.

    Furthermore, the stock market has a long track record of high volatility. This means that always being ready for a sudden fall in share prices could be a sound move.

    Of course, many stocks currently offer wide margins of safety, and may therefore be worth buying today despite the risk of a further drop in the price levels of indexes such as the S&P 500 and FTSE 100.

    A second stock market crash

    The second half of 2020 could include a second market crash after the initial decline and subsequent rebound recorded in the first half of the year. Risks such as an increase in coronavirus cases, as well as geopolitical uncertainty in the US and Europe, may contribute to more challenging operating conditions across many sectors. This may cause investor sentiment to weaken, which could disrupt the share price growth prospects for many businesses.

    Of course, the stock market has a long history of high volatility. Even if a further decline in share prices does not occur over the near term, the next bear market is almost certain to take place in the coming years. No stock market index has ever risen without experiencing downturns and bear markets, which means that investors should always be ready to react to attractive stock prices that may only be available for a short time period.

    Having some cash available to invest whenever a market crash occurs could be a potential solution to the prospect of a decline in share prices. It may act as a drag on your portfolio’s performance in the short run due to the low returns on savings accounts, but could allow you to capitalise on undervalued opportunities.

    Buying shares today

    Of course, another market crash may not occur for many years. Investor sentiment has improved in recent months, and the risks facing the world economy may already be priced in to market valuations.

    As such, now could be the right time to buy high-quality businesses at low prices. Certainly, some sectors have risen significantly in value over recent months, and may now offer unfavourable risk/reward opportunities. However, other sectors still appear to be undervalued based on their long-term recovery prospects and the financial positions of their incumbents.

    Therefore, investors who can adopt a long-term time horizon and look beyond short-term risks of a second market crash may wish to add stocks to their portfolios. This may not lead to high returns in the coming months, but may significantly improve your portfolio’s value as the world economy and stock prices gradually recover from an extremely challenging period.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor Peter Stephens has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why I’d start planning for stock market crash part 2 today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2WUd91Q

  • My 5-minute bull case for the Bubs share price

    baby, milk, formula, bellamy's, bubs

    I think that the Bubs Australia Ltd (ASX: BUB) share price is a buy. I’m going to outline my bull case for it in this article.

    A quick overview of what Bubs does

    Bubs was founded in 2006 by Kristy Carr. The company sells a variety of products with a focus on infant formula products and baby food, particularly goat milk products. It also sells other goat milk products and Jersey milk products.

    Here are the main reasons why I think, at this share price, Bubs is a great business to buy:

    Strong growth with international earnings

    The biggest point about the company is that it’s delivering strong results.

    Each result that Bubs releases shows strong revenue growth by the company. In the FY20 half year result it showed revenue growth of 37% to $28.75 million. In the quarter ending 31 March 2020, its revenue jumped by 67% to $19.7 million – up 36% on the previous quarter.

    Whilst the current revenue numbers it’s reporting aren’t big in absolute terms, compound growth could mean the company quickly becomes much larger if it keeps growing strongly at a high double digit rate.

    It’s the international growth that particularly excites me about the revenue growth. In the FY20 third quarter, Chinese revenue went up 104% and represented about a quarter of total sales. ‘Other markets’ revenue went up almost 20 times, with large growth into Vietnam – this segment now represents 12% of gross sales.

    Ultimately, a business with ‘potential’ needs to deliver the growth to grow its value and lead to a sustainable increase in the Bubs share price over time.

    I’m going to try to explain some of the points of why the Bubs revenue and the Bubs share price are growing so strongly.

    Expanding distribution network

    A key part of success for a consumer product business is to get its products in front of more potential consumers. That means into more stores, more websites and more countries.

    In terms of exports, its products are going to China, South East Asia and the Middle East. The ‘other market’ regions are a big addressable market for Bubs.

    Bubs has made a number of deals to expand its distribution network. For example, it has distribution agreements with Alibaba’s Tmall and Beingmate.

    In Australia, Bubs products are sold across hundreds of stores with major distribution agreements with Chemist Warehouse, Woolworths Group Ltd (ASX: WOW), Coles Group Limited (ASX: COL) and Baby Bunting Group Ltd (ASX: BBN).

    Bubs recently signed a new deal to expand its distribution of organic grass fed infant formula with Coles and Woolworths. That announcement sent the Bubs share price higher by 10%.

    High level of control of its supply chain

    Bubs boasts of being Australia’s only vertically integrated producer of goat milk formula, with exclusive milk supply from Australia’s largest milking goat herd after the acquisition of NuLac Foods.

    Last year the company announced the acquisition of the Deloraine manufacturing facility for $35 million. It was a key acquisition because, at the time, it was only one of 15 licenced canning facilities in Australia authorised by the certification and accreditation administration of China (CNCA) for physical importation into China under regulatory requirements administered by state administration for market regulation (SAMR). These approved manufacturers are key for getting product into China. 

    At the time of the acquisition, the company also raised $31.4 million at a share price for Bubs of $0.65. It’s up 57% since then.

    Rising gross profit margin

    One of the main factors for a market-beating ASX share is rising profit margins. Economies of scale are important.

    Bubs has reported a steadily growing gross profit margin over the past four results. In June 2018 the gross margin was 14%, in December 2018 it had a 19% gross margin, in June 2019 it had a gross margin of 21% and in December 2019 it had a gross margin of 24%.

    Bubs said it is doing effective cost management on a fixed milk price and more of the products sold are the higher margin infant formula products. In the December 2019 result the infant formula gross margin was 41%.

    As the business gets bigger, Bubs will become more profitable for each extra dollar of revenue generated.

    Cashflow positive

    An important stage for every fast-growth company is reaching cashflow status. The company has had to do a number of capital raisings at a lower Bubs share price to reach its current size and strength. When a business becomes cashflow positive it can start funding its own growth.

    In the three months to 31 March 2020, Bubs saw positive operating cashflow of $2.3 million. That’s not a lot, but the fact it’s now positive is a big plus. Bubs also had $36.4 million of cash on the balance sheet at 31 March 2020. It’s in a strong financial position. 

    Good strategy and focused management

    I’ve been very impressed by the partnerships, acquisitions and expansion that Bubs has done since it listed on the ASX.

    Kristy Carr and the team around her have done a great job of building the business into what it is today.

    It’s a good sign when the founder of the business has stayed with the business since it was founded. Mrs Carr’s holding is now 2.43% of the issued share capital. That’s not a large position, but it’s still worth over $13 million at the current Bubs share price.

    Foolish takeaway

    I think Bubs is one of the most promising ASX shares around. In five years I think Bubs could be a much larger business, making good profit with a strong international presence. At the current Bubs share price I’d be happy to start with a sizeable position for the long-term.

    Legendary stock picker names 5 cheap stocks to buy right now

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has stumbled upon five stocks he believes could be some of the greatest discoveries of his investing career.

    These little-known ASX stocks are growing like gangbusters, yet you can buy them today for less than $5 a share. Click here to learn more.

    See these 5 cheap stocks

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended BUBS AUST FPO. The Motley Fool Australia owns shares of COLESGROUP DEF SET. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post My 5-minute bull case for the Bubs share price appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/30KZtHH

  • Is now the time to sell your ASX shares?

    laptop keyboard with red sell button

    The ASX has had a tremendous run over the past few months. Since its lows in late-March the S&P/ASX200 Index (ASX:XJO) has surged nearly 37%. However, in my opinion there are a few headwinds that could be facing investors in the near future. Here are some factors to take into consideration when deciding whether or not to sell your ASX shares.  

    Have ASX shares run too far?

    Around 4 months ago during the height of market volatility, many investors were unsure how companies would ever recover, let alone ever trade at all time highs again. What has transpired over the last few months has been astounding, with some ASX shares making once in a lifetime moves.

    A great example of this is Afterpay Ltd (ASX: APT), which hit a low of $8.90 in late March. Many investors questioned how buy now, pay later users would be able to meet their repayment obligations. Despite the pessimism, government income support and the rush to online and cashless retail has fuelled demand for the company’s services.

    These moves have not been limited to technology companies, with online retailers like Kogan.com Ltd (ASX: KGN) and meal-kit provider Marley Spoon AG (ASX: MMM) also harnessing the change in consumer behaviour.

    Despite government stimulus and certain companies buoying the overall market, many investors might be looking to take profits after such a miraculous run. A gloomy budget deficit, high unemployment forecasts and the looming reporting season could also serve as catalyst for a pullback.

    Be wary of the upcoming reporting season

    The upcoming reporting season in August is set to be one of the most complex and volatile seasons in recent history. The United States reporting season, which is currently underway, has provided a glimpse of the uncertainty and volatility Australian investors can expect.

    Heading into reporting season, many investors would be relatively optimistic given there have not been a significant number of earnings downgrades. However, like all reporting seasons, there are bound to be some surprises.

    What to watch this reporting season

    It will be interesting to see how companies disclose the impact of the pandemic to investors and how the market will react. Furthermore, with many ASX companies implementing cost-cutting strategies to protect their balance sheets, it will also be fascinating to see how dividend payout ratios are impacted. Shares in the travel sector are already expected to report badly whereas there is more optimism for shares in the health sector. Reporting season will provide an opportunity to find out exactly how the pandemic has impacted the bottom line of companies in the tech sector. Meanwhile, the results for ASX bank shares are also likely to provide good insight into the country’s recovery prognosis.

    Foolish takeaway

    As a long-term investor I would usually advocate for shareholders to stay invested through the regular troughs and peaks of the sharemarket. However, the share price moves and general market volatility we have seen during the pandemic are an anomaly. Rather than selling the lot, another prudent strategy investors could adopt would be to sell a portion of their holdings to lock in profits. This would keep them invested whilst also freeing up some capital to take advantage of more opportunities that could arise during the August reporting season. 

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended Kogan.com ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Is now the time to sell your ASX shares? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3f1bqOy

  • 3 reasons why the Macquarie share price could be a buy

    macquarie share price

    In this article I’m going to tell you about three reasons why the Macquarie share price could be a buy.

    Macquarie is an investment bank that can trace its history back to 1969. It’s now one of Australia’s largest businesses with a market capitalisation of around $45 billion according to the ASX.

    The business boasts of a record of 51 years of unbroken profitability. That’s a very solid record for a financial business in my opinion.

    The Macquarie share price has recovered strongly since March 2020 – it’s up almost 75% since 23 March 2020 after the 52.5% drop to $72.

    But is it a still a buy? I think there are three reasons why I’d consider the Macquarie share price over other ASX blue chip shares:

    International earnings

    Plenty of the biggest businesses on the ASX are mostly focused on the domestic economy like the banks, Telstra Corporation Ltd (ASX: TLS), Coles Group Limited (ASX: COL) and Wesfarmers Ltd (ASX: WES).

    Macquarie only generates a third of its income from Australia and New Zealand. Meaning that international income account for two thirds of the business. The Americas accounted for a quarter of income in FY20, Asia made up 13% of total income and EMEA (Europe, the Middle East and Africa) accounted for 29% of total income. Macquarie’s share price would be nowhere near as high today without the international earnings. 

    I think that’s very important. The economies of Australia and New Zealand are sizeable, but obviously the entire world’s economy is much larger. So it’s better to be able to service the entire globe. It means Macquarie can invest into any region it wants to, wherever it thinks will produce the best return for its money.

    Diversified divisions

    Macquarie is probably one of the most diverse businesses among the ASX 20. It has four main segments: Macquarie Asset Management (MAM), banking and financial services, Macquarie Capital and commodities and global markets. The earnings diversification has been helpful for the recovery of the Macquarie share price this year in my opinion. For example, IPOs have dropped off but ASX capital raisings have been frequent. 

    Plenty of ASX shares are reliant on just one or two main sections to generate profit. But Macquarie makes good profit from each of its divisions. 

    Macquarie describes half of its business as ‘annuity style’, meaning it’s defensive and generates consistent income. That refers to MAM and the banking divisions. I’m not sure banking is particularly annuity-like – particularly during COVID-19 – but managing assets is a great earnings stream. Macquarie’s assets under management had grown to $606.9 billion at 31 March 2020. That’s a great benefit to Macquarie.

    The best bank

    I think Macquarie is by far the best large bank on the ASX.

    The big four ASX banks of Commonwealth Bank of Australia (ASX: CBA), Westpac Banking Corp (ASX: WBC), Australia and New Zealand Banking Group (ASX: ANZ) and National Australia Bank Ltd (ASX: NAB) are not terrible businesses – they just don’t offer much growth or earnings diversification. Loans are not a high-growth area and not very defensive. The Macquarie share price has recovered better than the big four ASX banks’.

    I wouldn’t want to diversify my portfolio by buying one of the big four because I believe it would lower my long-term investment returns. But Macquarie has proven it can be a good performer through the economic cycle.

    I think Macquarie also showed its quality through the Hayne royal commission. It barely featured whereas the big ASX banks had their reputations tarnished and had to repay large sums of money. 

    At this share price, is Macquarie a buy?

    I’d much rather buy Macquarie than most other blue chips due to its ability to grow anywhere. At the current Macquarie share price it’s trading at 16x FY22’s estimated earnings. I think that’s a reasonable price to pay for Macquarie shares considering a good amount of dividend income should be paid over the long-term as well, though the dividend is a bit uncertain due to COVID-19 at the moment. 

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited and Telstra Limited. The Motley Fool Australia owns shares of COLESGROUP DEF SET and Wesfarmers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 reasons why the Macquarie share price could be a buy appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2Bunl9O

  • You should watch this key metric during the reporting season that others often overlook

    Share tips

    The upcoming profit reporting season will keep investors on the edge of their seats and you shouldn’t forget to scrutinise one often overlooked detail in the results.

    This is the cash conversion ratio, which most investors either do not know about or brush aside for earnings multiples and growth figures.

    Don’t get me wrong, price-earnings (P/E) ratios and sales and earnings growth are still important details this time round, as they are for every reporting season.

    Cash ratio as important as profit ratio

    But the cash conversion ratio (CCR) is particularly relevant in this COVID-19-stricken market. You’ll see why after I explain what this ratio is.

    The CCR measures the amount of cash a company collects as a percentage of earnings. Just because an ASX stock reports a $100 profit, it doesn’t mean it receives $100 in cash.

    Calculating the CCR is easy although few companies will do it for you when highlighting their profit and sales performance for the year.

    How to calculate the cash conversion ratio

    To get the ratio, you take the net operating cash flow (from the cash flow statement) and divide that by the reported earnings before interest, tax, depreciation and amortisation (EBITDA).

    Don’t get confused by the cash flow statement as it is broken into three sections – operations, investing and financing. Cash flow from operations reflects the cash a company gets from its ordinary business and what it pays to provide the service or products, and that’s the net figure you want.

    Some calculate the CCR by dividing the cash flow with net profits instead. I prefer to use the EBITDA number as amortisation and depreciation charges do not impact on cash and it produces a “cleaner” ratio.

    Why cash doesn’t match profit

    In the vast majority of cases, you will find that the net cash from operations falls short of EBITDA. This shortfall can be significant too and will vary from sector to sector.

    The general rule of thumb is that a company with a CCR of 80% or better is good. If the ratio falls below this, you should investigate why as it could be an early indication of a problem.

    So why does a company’s reported EBITDA not match the cash it receives? There are a few reasons for this. It could be a timing issue where a company recognises the profit from a sale before it gets paid by the customer.

    Another common reason is an expansion in the company’s working capital, perhaps to fund a build-up in inventory.

    Early warning sign

    That could be a bullish sign if management is expecting a big ramp up in near-term sales or is gearing up for the start of a big project.

    But in this coronavirus recessionary environment, a material increase in working capital could be a warning sign instead as most businesses will be experiencing declining sales.

    Further, many ASX companies are probably feeling a cash crunch from the COVID-19 fallout. Booking decent profits isn’t enough to stave-off a capital raising if the cash isn’t coming in fast enough.

    Final thoughts

    As I’ve written last week, capital raisings are one of the key features I am expecting during the reporting season. Paying attention to the CCR could provide an early clue of a company in need of fresh capital.

    As a final thought, the CCR is more relevant to S&P/ASX 200 Index (Index:^AXJO) companies than small caps.

    Market minnows often don’t have earnings and are still making losses. You can’t use the ratio if the EBIDTA number is negative.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. Connect with me on Twitter @brenlau.

    The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post You should watch this key metric during the reporting season that others often overlook appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3htIOiC

  • Why investing in super can turbocharge your returns

    depositing coin into piggy bank for super, invest in super, grow super

    It’s the age-old question: should I be investing in super?

    The Aussie superannuation system can be divisive. Many, particularly the younger cohort, are reluctant to invest additional cash into their super funds.

    However, I’m a big believer in the power that super funds can have to turbocharge retirement plans.

    Here are a few reasons why investing more money in super can be a great idea for investors of all ages.

    Concessional contributions are taxed at 15%

    This is a really big factor in favour of investing in super. Concessional contributions up to $25,000 per year are taxed at just 15% by super funds.

    For reference, every dollar earned between $18,200 and $37,000 is taxed at 19%. Beyond that, Aussies are taxed progressively at 32.5%, 37% and up to 45% per dollar above $180,000 per year.

    That means investing in super as concessional contributions can generate a significant tax break. As a long-term investor myself, that seems like a no-brainer.

    I plan on using that money at 65+ anyway, so I might as well save some tax along the way.

    Investing in super means less tax on capital gains

    This is another big consideration but one that is often overlooked.

    A capital gains event generally occurs when an asset is sold. If that is outside of super and the asset has been held for over 12 months, the investor would get taxed at their marginal tax rate.

    However, capital gains within super get another handy tax break. During the accumulation phase, super funds typically receive a one-third discount on any capital gains made.

    Given super funds are taxed at the flat 15% rate, that means the capital gain would be taxed at effectively 10%.

    That’s compared to anywhere between 19% to 45% for investing outside of super if you earn upwards of $18,200 per year.

    Super funds can invest big and long-term

    Super funds have large pools of capital to invest across their various strategies. That means investing in super can get you access to investments that would otherwise not be possible.

    This includes allocations to private equity, hedge funds and infrastructure assets. These investments can generate liquidity premiums and boost overall returns.

    Investing in super is just one part of your strategy

    The good news is, it doesn’t have to be all or nothing when it comes to investing in your superannuation. You can still keep your investments outside of super, but you may need less of them.

    For instance, you could build up a sizeable portfolio of ASX shares or hold a broad market ETF like BetaShares Australia 200 ETF (ASX: A200) alongside your growing superannuation fund.

    If you retire early, you simply draw down your ETF holdings outside of super down to zero until preservation age.

    From there, your super investment kicks in and you can have a happy retirement.

    But… there are drawbacks

    Of course, if it was all good news, everyone would be investing more in super with no questions asked.

    The reality is that there is an opportunity cost of contributing more to your superannuation.

    That money is locked away for a long time and could be otherwise deployed elsewhere. For instance, you could buy ASX shares outside of super, pay down debt or save for a home deposit.

    The First Home Super Saver (FHSS) scheme does help to alleviate this in some sense, but not completely.

    There’s also a significant regulatory risk. Many investors worry that the preservation age will change by the time they retire.

    The government could also view super as a convenient way to pay back deficits through higher taxes.

    Foolish takeaway

    In the end, investing additional money in super is a personal choice. However, I think the benefits outweigh the potential risks for me as it currently stands.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why investing in super can turbocharge your returns appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2WYE2St

  • Sorrento Therapeutics May Be Ready For a Pullback

    Sorrento Therapeutics May Be Ready For a PullbackSan Diego-based Sorrento Therapeutics (NASDAQ:SRNE) has become one of the hottest biopharmaceutical companies investors are watching in the rush to find a cure for the novel coronavirus. So far in the year, SRNE stock is up around 130%.Source: luchschenF / Shutterstock.com However, that number tells only half the story. In mid-March, Sorrento shares hit a recent low of $1.55. Now they are flirting with $8. That is an increase of about 400%.Put another way, $1,000 invested in SRNE stock in early spring would now be worth over $5,000.InvestorPlace – Stock Market News, Stock Advice & Trading TipsTherefore, today, I'll take a closer look at whether long-term investors should consider committing new capital into Sorrento Therapeutics. Why Investors Became Interested in SRNE StockSorrento is a clinical-stage and commercial biopharma company. Until recently, its emphasis was on immuno-oncology and non-opioid pain management. It has been working on therapies to "improve the lives of those who suffer from cancer [and] intractable pain." * 10 Cybersecurity Stocks We Need Now More Than EverThis year brought another dimension its efforts, i.e., its aggressive research on the novel coronavirus.The company claims that the immuno-oncology portfolio will allow it to develop multimodal therapies to "attack harmful cells frequently and relentlessly" and "generate the next generation of cancer therapeutics." In addition, it now has several Covid-19 therapy candidates.In fact, management is hopeful about having antibody ready by this fall. In recent weeks, SRNE stock has moved along with each news release by the company on the developments regarding their coronavirus-related trials.For example, following a press release on July 20, it surged close to 20%. The FDA gave the green light to Abivertinib for Phase 2 safety and efficacy study in hospitalized patients with moderate to severe Covid-19. The results would likely be important for patients "hospitalized with developing cytokine storm in the lungs." What Could Derail SRNE StockThe health and economic effects of the pandemic worldwide has fueled investors' love affair with small biotech firms as well as the big pharma.I'd encourage potential investors to read the company's latest 10-Q SEC filing where management highlights several important risk factors. It says, "We are a clinical stage company subject to significant risks and uncertainties, including the risk that we or our partners may never develop, obtain regulatory approval or market any of our product candidates or generate product related revenues."The next stage is in the efforts to develop a Covid-19 vaccine is expected to involve animal studies. And following potential successful results, human trials would be likely. However, the road is a long and potentially difficult one.Management also draws attention to the fact that it has "incurred significant losses since inception and [is likely to] incur continued losses for the foreseeable future." In the quarter that ended March 31, net revenue came $7.7 million. Net losses were more than $69 million.Developing effective therapies can be extremely costly, putting immense pressure, especially on a small company's capital structure. And the competition to develop a cure for the novel corona virus is intense. In addition to Sorrento, several other companies are currently working on vaccine or drug development. They include AstraZeneca (NYSE:AZN), GlaxoSmithKline (NYSE:GSK), Inovio Pharmaceuticals (NASDAQ:INO), Moderna (NASDAQ:MRNA), Novavax (NASDAQ:NVAX) and Pfizer (NYSE:PFE).It'd be important to remember that big pharma can not only discover a vaccine or drug, but also produce it in mass quantities, which is an essential part of the equation. Therefore, in the second half of the year, market participants may decide to de-risk away from smaller companies such as Sorrento.Instead, they may want to concentrate on more established names with established R&D and manufacturing facilities. Bottom Line for SRNE StockShares of many biotech companies, including SRNE stock, have seen stunning gains this year, especially since late March. Now market participants are wondering if they are somewhat late to the party or if the stock could indeed go up any further. Seasoned investors realize that big sums can be made or lost by taking a bet on a potential cure that may be developed by otherwise a small biotechnology company.Unless the company comes up with tangible results, some profit-taking in SRNE stock may be likely. Therefore, if you are an investor with paper profits, you may want to take some capital off the table.In the long run, if the company can successfully reach the finish line and develop a therapy that is accepted by global authorities, then early shareholders are likely to be rewarded even further. Potential long-term investors should appreciate the given risk/return profile of a small biotechnology company and remember that SRNE is a highly volatile stock. It makes rather substantial moves, both up and down on a daily basis.Finally, in case the company's efforts are successful, it could easily find itself a takeover candidate. Needless to say, such a development would benefit investors in SRNE stock.Tezcan Gecgil has worked in investment management for over two decades in the U.S. and U.K. In addition to formal higher education, including a Ph.D. in the field, she has also completed all 3 levels of the Chartered Market Technician (CMT) examination. Her passion is for options trading based on technical analysis of fundamentally strong companies. She especially enjoys setting up weekly covered calls for income generation. As of this writing, Tezcan Gecgil holds PFE covered calls (July 31 expiry). More From InvestorPlace * Why Everyone Is Investing in 5G All WRONG * America's 1 Stock Picker Reveals His Next 1,000% Winner * Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company * Radical New Battery Could Dismantle Oil Markets The post Sorrento Therapeutics May Be Ready For a Pullback appeared first on InvestorPlace.

    from Yahoo Finance https://ift.tt/2CGOAyK